A citation-based method for searching scientific literature

Joseph E Ebinger, Justyna Fert-Bober, Ignat Printsev, Min Wu, Nancy Sun, John C Prostko, Edwin C Frias, James L Stewart, Jennifer E Van Eyk, Jonathan G Braun, Susan Cheng, Kimia Sobhani. Nat Med 2021
Times Cited: 327







List of co-cited articles
488 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
39

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Florian Krammer, Komal Srivastava, Hala Alshammary, Angela A Amoako, Mahmoud H Awawda, Katherine F Beach, Maria C Bermúdez-González, Dominika A Bielak, Juan M Carreño, Rachel L Chernet,[...]. N Engl J Med 2021
436
36

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
David S Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E Schlub, Adam K Wheatley, Jennifer A Juno, Kanta Subbarao, Stephen J Kent, James A Triccas, Miles P Davenport. Nat Med 2021
29

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
27

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.
Rishi R Goel, Sokratis A Apostolidis, Mark M Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, Sigrid Gouma, Philip Hicks, Wenzhao Meng, Aaron M Rosenfeld,[...]. Sci Immunol 2021
314
25

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.
Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, Einav Gal Levin, Carmit Rubin, Victoria Indenbaum,[...]. N Engl J Med 2021
633
22

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
Charlotte Manisty, Ashley D Otter, Thomas A Treibel, Áine McKnight, Daniel M Altmann, Timothy Brooks, Mahdad Noursadeghi, Rosemary J Boyton, Amanda Semper, James C Moon. Lancet 2021
247
21

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Jennifer M Dan, Jose Mateus, Yu Kato, Kathryn M Hastie, Esther Dawen Yu, Caterina E Faliti, Alba Grifoni, Sydney I Ramirez, Sonya Haupt, April Frazier,[...]. Science 2021
18

Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
Maria Prendecki, Candice Clarke, Jonathan Brown, Alison Cox, Sarah Gleeson, Mary Guckian, Paul Randell, Alessia Dalla Pria, Liz Lightstone, Xiao-Ning Xu,[...]. Lancet 2021
197
17

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, Leah J Homad, Vanessa Rubin, Hayley Glantz, Moni Neradilek, Emilie Seydoux, Madeleine F Jennewein, Anna J MacCamy,[...]. Science 2021
298
16

Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection.
Federico Gobbi, Dora Buonfrate, Lucia Moro, Paola Rodari, Chiara Piubelli, Sara Caldrer, Silvia Riccetti, Alessandro Sinigaglia, Luisa Barzon. Viruses 2021
83
18

Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.
Saman Saadat, Zahra Rikhtegaran Tehrani, James Logue, Michelle Newman, Matthew B Frieman, Anthony D Harris, Mohammad M Sajadi. JAMA 2021
222
14

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
Zijun Wang, Frauke Muecksch, Dennis Schaefer-Babajew, Shlomo Finkin, Charlotte Viant, Christian Gaebler, Hans- Heinrich Hoffmann, Christopher O Barnes, Melissa Cipolla, Victor Ramos,[...]. Nature 2021
344
13

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. N Engl J Med 2020
13

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
Jeffrey Seow, Carl Graham, Blair Merrick, Sam Acors, Suzanne Pickering, Kathryn J A Steel, Oliver Hemmings, Aoife O'Byrne, Neophytos Kouphou, Rui Pedro Galao,[...]. Nat Microbiol 2020
725
12

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination.
Lisa Müller, Marcel Andrée, Wiebke Moskorz, Ingo Drexler, Lara Walotka, Ramona Grothmann, Johannes Ptok, Jonas Hillebrandt, Anastasia Ritchie, Denise Rabl,[...]. Clin Infect Dis 2021
251
12

Evidence for antibody as a protective correlate for COVID-19 vaccines.
Kristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, David Goldblatt, Peter B Gilbert, George R Siber, Peter Dull, Stanley A Plotkin. Vaccine 2021
387
12

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
Ania Wajnberg, Fatima Amanat, Adolfo Firpo, Deena R Altman, Mark J Bailey, Mayce Mansour, Meagan McMahon, Philip Meade, Damodara Rao Mendu, Kimberly Muellers,[...]. Science 2020
701
11

Evolution of antibody immunity to SARS-CoV-2.
Christian Gaebler, Zijun Wang, Julio C C Lorenzi, Frauke Muecksch, Shlomo Finkin, Minami Tokuyama, Alice Cho, Mila Jankovic, Dennis Schaefer-Babajew, Thiago Y Oliveira,[...]. Nature 2021
818
11

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, Isabel Vogler, Lena M Kranz, Mathias Vormehr, Alina Baum, Kristen Pascal, Jasmin Quandt, Daniel Maurus,[...]. Nature 2020
959
11

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
Catherine J Reynolds, Corinna Pade, Joseph M Gibbons, David K Butler, Ashley D Otter, Katia Menacho, Marianna Fontana, Angelique Smit, Jane E Sackville-West, Teresa Cutino-Moguel,[...]. Science 2021
166
11

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
Lisa A Jackson, Evan J Anderson, Nadine G Rouphael, Paul C Roberts, Mamodikoe Makhene, Rhea N Coler, Michele P McCullough, James D Chappell, Mark R Denison, Laura J Stevens,[...]. N Engl J Med 2020
11

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
Einav G Levin, Yaniv Lustig, Carmit Cohen, Ronen Fluss, Victoria Indenbaum, Sharon Amit, Ram Doolman, Keren Asraf, Ella Mendelson, Arnona Ziv,[...]. N Engl J Med 2021
622
11

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
Sheila F Lumley, Denise O'Donnell, Nicole E Stoesser, Philippa C Matthews, Alison Howarth, Stephanie B Hatch, Brian D Marsden, Stuart Cox, Tim James, Fiona Warren,[...]. N Engl J Med 2021
522
10

First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.
Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, Lorenzo Salvati, Anna Vanni, Manuela Capone, Giulia Lamacchia, Elisabetta Mantengoli, Michele Spinicci, Lorenzo Zammarchi,[...]. J Clin Invest 2021
73
13

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
Evan J Anderson, Nadine G Rouphael, Alicia T Widge, Lisa A Jackson, Paul C Roberts, Mamodikoe Makhene, James D Chappell, Mark R Denison, Laura J Stevens, Andrea J Pruijssers,[...]. N Engl J Med 2020
804
10

Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study.
Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, Virge Jürjenson, Ainika Adamson, Liis Haljasmägi, Anna Pauliina Rumm, Regina Maruste, Jaanika Kärner,[...]. Lancet Reg Health Eur 2021
265
10

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.
F Javier Ibarrondo, Jennifer A Fulcher, David Goodman-Meza, Julie Elliott, Christian Hofmann, Mary A Hausner, Kathie G Ferbas, Nicole H Tobin, Grace M Aldrovandi, Otto O Yang. N Engl J Med 2020
697
9

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Pedro M Folegatti, Katie J Ewer, Parvinder K Aley, Brian Angus, Stephan Becker, Sandra Belij-Rammerstorfer, Duncan Bellamy, Sagida Bibi, Mustapha Bittaye, Elizabeth A Clutterbuck,[...]. Lancet 2020
9

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Alba Grifoni, Daniela Weiskopf, Sydney I Ramirez, Jose Mateus, Jennifer M Dan, Carolyn Rydyznski Moderbacher, Stephen A Rawlings, Aaron Sutherland, Lakshmanane Premkumar, Ramesh S Jadi,[...]. Cell 2020
9

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
Jackson S Turner, Wooseob Kim, Elizaveta Kalaidina, Charles W Goss, Adriana M Rauseo, Aaron J Schmitz, Lena Hansen, Alem Haile, Michael K Klebert, Iskra Pusic,[...]. Nature 2021
249
9

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.
Jackson S Turner, Jane A O'Halloran, Elizaveta Kalaidina, Wooseob Kim, Aaron J Schmitz, Julian Q Zhou, Tingting Lei, Mahima Thapa, Rita E Chen, James Brett Case,[...]. Nature 2021
298
9

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
Noa Dagan, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A Katz, Miguel A Hernán, Marc Lipsitch, Ben Reis, Ran D Balicer. N Engl J Med 2021
9


Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.
Dami A Collier, Isabella A T M Ferreira, Prasanti Kotagiri, Rawlings P Datir, Eleanor Y Lim, Emma Touizer, Bo Meng, Adam Abdullahi, Anne Elmer, Nathalie Kingston,[...]. Nature 2021
266
9

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan,[...]. Lancet 2021
771
9

Antibody responses to SARS-CoV-2 in patients with COVID-19.
Quan-Xin Long, Bai-Zhong Liu, Hai-Jun Deng, Gui-Cheng Wu, Kun Deng, Yao-Kai Chen, Pu Liao, Jing-Fu Qiu, Yong Lin, Xue-Fei Cai,[...]. Nat Med 2020
8

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, Brian Angus, Vicky L Baillie, Shaun L Barnabas, Qasim E Bhorat,[...]. Lancet 2021
8

SARS-CoV-2 Antibody Response in Persons with Past Natural Infection.
Gabriele Anichini, Chiara Terrosi, Claudia Gandolfo, Gianni Gori Savellini, Simonetta Fabrizi, Giovanni B Miceli, M Grazia Cusi. N Engl J Med 2021
87
9

Waning Immunity after the BNT162b2 Vaccine in Israel.
Yair Goldberg, Micha Mandel, Yinon M Bar-On, Omri Bodenheimer, Laurence Freedman, Eric J Haas, Ron Milo, Sharon Alroy-Preis, Nachman Ash, Amit Huppert. N Engl J Med 2021
419
8

IgA dominates the early neutralizing antibody response to SARS-CoV-2.
Delphine Sterlin, Alexis Mathian, Makoto Miyara, Audrey Mohr, François Anna, Laetitia Claër, Paul Quentric, Jehane Fadlallah, Hervé Devilliers, Pascale Ghillani,[...]. Sci Transl Med 2021
495
8

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Shuo Feng, Daniel J Phillips, Thomas White, Homesh Sayal, Parvinder K Aley, Sagida Bibi, Christina Dold, Michelle Fuskova, Sarah C Gilbert, Ian Hirsch,[...]. Nat Med 2021
449
8

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Peter B Gilbert, David C Montefiori, Adrian B McDermott, Youyi Fong, David Benkeser, Weiping Deng, Honghong Zhou, Christopher R Houchens, Karen Martins, Lakshmi Jayashankar,[...]. Science 2022
346
8

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera,[...]. N Engl J Med 2021
8

Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine.
Valerie Oberhardt, Hendrik Luxenburger, Janine Kemming, Isabel Schulien, Kevin Ciminski, Sebastian Giese, Benedikt Csernalabics, Julia Lang-Meli, Iga Janowska, Julian Staniek,[...]. Nature 2021
126
7

A serological assay to detect SARS-CoV-2 seroconversion in humans.
Fatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, Thi H O Nguyen, Veronika Chromikova, Meagan McMahon, Kaijun Jiang, Guha Asthagiri Arunkumar, Denise Jurczyszak, Jose Polanco,[...]. Nat Med 2020
7

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
Carolyn Rydyznski Moderbacher, Sydney I Ramirez, Jennifer M Dan, Alba Grifoni, Kathryn M Hastie, Daniela Weiskopf, Simon Belanger, Robert K Abbott, Christina Kim, Jinyong Choi,[...]. Cell 2020
900
7

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
Ugur Sahin, Alexander Muik, Isabel Vogler, Evelyna Derhovanessian, Lena M Kranz, Mathias Vormehr, Jasmin Quandt, Nicole Bidmon, Alexander Ulges, Alina Baum,[...]. Nature 2021
293
7

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.
Jia Wei, Nicole Stoesser, Philippa C Matthews, Daniel Ayoubkhani, Ruth Studley, Iain Bell, John I Bell, John N Newton, Jeremy Farrar, Ian Diamond,[...]. Nat Microbiol 2021
125
7

One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19.
Riccardo Levi, Elena Azzolini, Chiara Pozzi, Leonardo Ubaldi, Michele Lagioia, Alberto Mantovani, Maria Rescigno. J Clin Invest 2021
60
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.